Enverdis Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Enverdis General Information

Description

Developer of medical technology products designed to cure Acute Coronary Syndrome. The company's products include cardiologic explorer, electrocardiography and cardiogoniometry system for identification of myocardial ischemia, detection of perfusion malfunction and late enhancement, enabling people to manage hypertension and detect arteriosclerotic vascular lesions.

Contact Information

Formerly Known As
Medtrans
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Furstenwall 63
  • 40219 Dusseldorf
  • Germany
+49 0211
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Vertical(s)
Corporate Office
  • Furstenwall 63
  • 40219 Dusseldorf
  • Germany
+49 0211

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enverdis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 18-Jan-2018 Completed Generating Revenue
1. Early Stage VC 01-May-2014 Completed Startup
To view Enverdis’s complete valuation and funding history, request access »

Enverdis Patents

Enverdis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2269502-A1 Method and device for determining an arterial closing and/or opening pressure in a blood vessel Inactive 29-Jun-2009
EP-2166933-A1 Method for determination of a quasi-continuous blood pressure change in a pulsatile blood stream Inactive 24-Jul-2007
WO-2009013287-A1 Method for determination of a quasi-continuous blood pressure change in a pulsatile blood stream Inactive 24-Jul-2007
DE-102007014583-B3 Blood components concentration determination device for diagnosing micro-vascular damages, has computing device computing absorption of emitted measuring radiation based on measured reflected and transmitted radiation portions Inactive 23-Mar-2007
JP-2010521267-A How to measure microvascular lesions Inactive 23-Mar-2007 A61B5/0261
To view Enverdis’s complete patent history, request access »

Enverdis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enverdis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pall Mall Partners Venture Capital Minority
To view Enverdis’s complete investors history, request access »

Enverdis FAQs

  • When was Enverdis founded?

    Enverdis was founded in 1997.

  • Where is Enverdis headquartered?

    Enverdis is headquartered in Dusseldorf, Germany.

  • What is the size of Enverdis?

    Enverdis has 6 total employees.

  • What industry is Enverdis in?

    Enverdis’s primary industry is Diagnostic Equipment.

  • Is Enverdis a private or public company?

    Enverdis is a Private company.

  • What is Enverdis’s current revenue?

    The current revenue for Enverdis is .

  • Who are Enverdis’s investors?

    Pall Mall Partners has invested in Enverdis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process